ABT-263对顺铂耐药食管癌细胞的抑制作用(4)
[14] Chen Q，Song S，Wei S，et al. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer [J]. Oncotarget，2015， 6(28)：25883-25896.
[15] Lin QH，Que FC，Gu CP，et al. ABT-263 induces G1/G0-phase arrest，apoptosis and autophagy in human esophageal cancer cells in vitro [J]. Acta Pharmacol Sin，2017，38(12)：1632-1641.
[16] 郗照勇，刘扬中.顺铂耐药的分子机制[J].中国科学：化学，2014，44(4)：410-422.
[17] Cheng CY，Liu JC，Wang JJ，et al. Autophagy inhibition increased the anti-tumor effect of cisplatin on drug-resistant esophageal cancer cells [J]. J Biol Regul Homeost Agents，2017，31(3)：645-652.
[18] Shi H，Mao Y，Ju Q，et al. C-terminal binding protein2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis [J]. Int J Oncol，2018， 53(1)：167-176.
[19] Hou XF，Xu LP，Song HY，et al. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA [J]. World J Gastroenterol，2017，23(10)：1796-1803.
[20] Yokoyama T，Kohn EC，Brill E，et al. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP [J]. Int J Oncol，2017. [Epub ahead of print]
(收稿日期：2018-07-29 本文編辑：罗乔荔), 百拇医药(林庆焕 丁茸 毕婷婷 林健 邓贵华)
[15] Lin QH，Que FC，Gu CP，et al. ABT-263 induces G1/G0-phase arrest，apoptosis and autophagy in human esophageal cancer cells in vitro [J]. Acta Pharmacol Sin，2017，38(12)：1632-1641.
[16] 郗照勇，刘扬中.顺铂耐药的分子机制[J].中国科学：化学，2014，44(4)：410-422.
[17] Cheng CY，Liu JC，Wang JJ，et al. Autophagy inhibition increased the anti-tumor effect of cisplatin on drug-resistant esophageal cancer cells [J]. J Biol Regul Homeost Agents，2017，31(3)：645-652.
[18] Shi H，Mao Y，Ju Q，et al. C-terminal binding protein2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis [J]. Int J Oncol，2018， 53(1)：167-176.
[19] Hou XF，Xu LP，Song HY，et al. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA [J]. World J Gastroenterol，2017，23(10)：1796-1803.
[20] Yokoyama T，Kohn EC，Brill E，et al. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP [J]. Int J Oncol，2017. [Epub ahead of print]
(收稿日期：2018-07-29 本文編辑：罗乔荔), 百拇医药(林庆焕 丁茸 毕婷婷 林健 邓贵华)